Objective: We evaluated the utility of preoperative midregional (MR) pro-adrenomedullin
(proADM) and cardiac troponin T (TnT) for improved detection of patients at high risk for …

Objectives: Risk assessment in ICU patients using commonly used prognostic models may
be influenced using different data definitions and by errors in data collection. We …

Background and Objectives: the cardiovascular adverse events including mortality and heart
failure, persist significantly during the first months after the acute phase of ST-segment …

Introduction Various clinical scores have been developed to predict organ dysfunction and
mortality in patients undergoing cardiac surgery, but outcome prediction may be inaccurate …

Background: Patients undergoing vascular surgery are prone to perioperative organ injury
because of both higher prevalence of cardiovascular risk factors and the extent of surgery …

Objective To assess the cardiovascular prognostic value of mid-regional pro-
adrenomedullin (MR-proADM) and compare this with B-type natriuretic peptide (BNP) and N …

Background N-terminal-proBNP (NT-proBNP) and Midregional-pro-Adrenomedullin (MR-
proADM) predict mortality of patients with acute myocardial infarction (AMI). Comparison of …

Objectives: This study sought to assess the prognostic impact of midregional pro-
adrenomedullin (MR-proADM) after an acute myocardial infarction (AMI). Background …

Background Identifying Intensive Care Unit (ICU) patients with sepsis and predicting the risk
of death are unmet clinical needs. Methods Prospective observational single-center study of …

Background: Midregional pro-adrenomedullin (MR-proADM) and endothelin-1 have been
shown to predict mortality of patients with acute myocardial infarction. However, the …